Quick Takeaways
- Vickie L. Capps has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,237,817.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Vickie L. Capps
- Location
- Vista, CA
- Summary
- The estimated net worth of Vickie L. Capps is at least $2,237,817 dollars as of 10 Mar 2026. Vickie L. Capps is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.89M. Vickie L. Capps is the Director of Orthofix Medical Inc. and owns shares of Orthofix Medical Inc. (OFIX) stock worth about $343.4K. Vickie L. Capps is the Director of OTONOMY, INC. and owns shares of OTONOMY, INC. stock worth about $440.
- Signature
- /s/ J. Andres Cedron, Attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Vickie L. Capps and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Janux Therapeutics, Inc. ($1,893,944).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Vickie L. Capps
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Director | $1,893,944 | 11 Jun 2025 | ||
| OFIX | Orthofix Medical Inc. | Director | $343,433 | +$62,324 | +22% | 09 Mar 2026 |
| OTIC | OTONOMY, INC. | Director | $440 | 28 Nov 2022 | ||
| AMED | AMEDISYS INC | Director | $0 | 14 Aug 2025 | ||
| NUVA | NUVASIVE INC | Director | 01 Sep 2023 | |||
| SPRY | Silverback Therapeutics, Inc. | Director | 10 Jun 2022 |
Insider Transactions Reported by Vickie L. Capps:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.